Delivery Order SPE2DB22D1106-SPE2DB24FDMG3
Award Date
11/17/23
Potential Completion Date
11/20/23
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,448.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,612.13 Firm Fixed Price Delivery Order covers the supply of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC...
This federal contract award, valued at $1,441.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product. The contract has an ultimate completion date of January 4, 2024 and is a firm-fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROTONIX 40 MG SUSPENSION 30S, a prescription medication. The contract has a ceiling value of $2,742.80 and a completion date of July 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous other federal contracts by the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,146.58 Firm Fixed Price Delivery Order is for the supply of PROTONIX 40 MG SUSPENSION 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2022 and was awarded on March 3, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
This federal contract award, valued at $3,172.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROTONIX 40 MG SUSPENSION 30S. The contract is a Firm Fixed Price Delivery Order with a completion date of June 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FUZCG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,333.32 firm-fixed-price delivery order is for the pharmaceutical product PROTONIX 40 MG SUSPENSION 30S. The contract has an ultimate completion date of October 25, 2023 and was awarded on October 24, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of the pharmaceutical product PROTONIX DR 40 MG TABLET 90S, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,791.55 firm-fixed-price delivery order has an ultimate completion date of February 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Protonix 40 mg suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,151.59, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 26, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.19 firm-fixed-price delivery order is for the supply of Protonix 40 mg suspension medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle...